Three years of experience: the Italian registry and safety data update
- 20 July 2010
- journal article
- research article
- Published by Springer Nature in Neurological Sciences
- Vol. 31 (3) , 295-297
Abstract
No abstract availableKeywords
This publication has 3 references indexed in Scilit:
- The pharmacovigilance program on natalizumab in Italy: 2 years of experienceNeurological Sciences, 2009
- Natalizumab: a country-based surveillance programNeurological Sciences, 2008
- A Randomized, Placebo-Controlled Trial of Natalizumab for Relapsing Multiple SclerosisNew England Journal of Medicine, 2006